Sequent Scientific Share Price
Small Cap | Pharmaceuticals and health care | NSE: SEQUENT | BSE: 512529
₹158.75 0.05 (0.03 %)
Last Updated: 21 Feb 2025 04:01 PM
Overview
Open (₹) 158.50
High (₹) 163.00
Low (₹) 155.65
Prev. Close (₹) 158.70
Volume 24,606
VWAP (₹) 155.90
ROCE (%) 1.18
Industry P/E 44.81
TTM P/E 214.53
P/B Ratio 5.58
Market Cap (₹) Cr.3,982.04
Dividend Yield (%)--
EPS (₹) -1.44
ROE-5.04%
Sales Growth (%) -3.6
Profit Growth (%)-75.72
Day Range
163.00163.00
52 Week Range
91.85240.90
Historical Returns
Returns (6M)
-4.08 %
Returns (1Y)
9.52 %
Returns (3Y)
12.83 %
Returns (5Y)
67.55 %
Returns (6M)
-4.08 %
Returns (1Y)
9.52 %
Returns (3Y)
12.83 %
Returns (5Y)
67.55 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Positive ROC (9) indicates upward momentum.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 52.45
MFI 30.23
ATR 9.22
Commodity Channel Index -32.93
ROC125 -4.48
ROC21 -10.77
Williams %R -32.21
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 163.20 | 167.70 | 175.80 | 155.10 | 150.60 | 142.50 | 138.00 |
Week Ago | 164.65 | 171.15 | 177.65 | 158.15 | 151.65 | 145.15 | 138.65 |
Month Ago | 184.39 | 187.82 | 193.79 | 178.42 | 174.99 | 169.02 | 165.59 |
EMA & SMA
158.75
Current Price
Bullish Moving Averages
12
Bearish Moving Averages
8
5 Day 149.33
9 Day 153.28
10 Day 153.97
12 Day 156.64
14 Day 156.37
20 Day 158.25
26 Day 162.86
50 Day 172.67
100 Day 185.48
200 Day 161.60
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
MILLENNIUM STOCK BROKING PVT LTD | bulk | Sell | 09 Dec, 2021 | ₹170.23 | 1,84,018 | BSE |
MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 09 Dec, 2021 | ₹162.34 | 2,75,412 | BSE |
INFINITY HOLDINGS | bulk | Sell | 09 Dec, 2021 | ₹157.02 | 1,46,85,986 | BSE |
GKN SECURITIES | bulk | Sell | 09 Dec, 2021 | ₹170.11 | 43,663 | BSE |
MILLENNIUM STOCK BROKING PVT LTD | bulk | Buy | 09 Dec, 2021 | ₹164.74 | 16,05,698 | BSE |
MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Buy | 09 Dec, 2021 | ₹155.01 | 12,83,113 | BSE |
GKN SECURITIES | bulk | Buy | 09 Dec, 2021 | ₹165.04 | 15,07,365 | BSE |
ASCENT INDIA FUND III | bulk | Sell | 14 Jan, 2021 | ₹200.00 | 40,00,000 | BSE |
K RAVISHANKAR | block | Sell | 20 Aug, 2020 | ₹127.90 | 39,50,000 | BSE |
ARUNKUMAR PILLAI | block | Sell | 20 Aug, 2020 | ₹127.90 | 1,17,50,000 | BSE |
CHAYADEEP VENTURES LLP | block | Buy | 20 Aug, 2020 | ₹127.90 | 1,17,49,965 | BSE |
AGNUS CAPITAL LLP | block | Buy | 20 Aug, 2020 | ₹127.90 | 1,17,50,000 | BSE |
K RAVISHANKAR | bulk | Sell | 20 Aug, 2020 | ₹127.90 | 78,99,930 | BSE |
ARUNKUMAR PILLAI | bulk | Sell | 20 Aug, 2020 | ₹127.90 | 2,34,99,965 | BSE |
PRONOMZ VENTURES LLP | block | Sell | 24 Jul, 2020 | ₹110.50 | 26,00,000 | BSE |
JSRAMAPRASAD JSRAMAPRASAD | block | Sell | 24 Jul, 2020 | ₹110.50 | 18,25,000 | BSE |
AGNUS HOLDINGS PRIVATE LIMITED | block | Buy | 24 Jul, 2020 | ₹110.50 | 26,00,000 | BSE |
JSRAMAPRASAD JSRAMAPRASAD | block | Sell | 16 Jul, 2020 | ₹105.30 | 54,93,250 | BSE |
AGNUS HOLDINGS PRIVATE LIMITED | block | Buy | 16 Jul, 2020 | ₹105.30 | 54,93,250 | BSE |
AGNUS CAPITAL LLP | block | Sell | 14 Jul, 2020 | ₹100.00 | 54,81,750 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
26 Dec, 2023 | Sequent Scientific Employee Stock Plan Trust | Disposal | ₹115.1150781818181818181818182 | 5,50,000 | BSE |
04 Apr, 2022 | Manish Gupta | Disposal | ₹138.4399988405573054551778778 | 1,03,498 | BSE |
04 Apr, 2022 | Manish Gupta | Disposal | ₹133.9499993138371598347719881 | 2,91,476 | BSE |
04 Apr, 2022 | Manish Gupta | Disposal | ₹130.1200016321201240411294271 | 98,032 | BSE |
04 Apr, 2022 | Manish Gupta | Disposal | ₹136.4799939202796671353117757 | 52,634 | BSE |
25 Mar, 2022 | Manish Gupta | Disposal | ₹133.03 | 3,00,000 | BSE |
25 Mar, 2022 | Manish Gupta | Disposal | ₹124.12 | 2,86,500 | BSE |
25 Mar, 2022 | Manish Gupta | Disposal | ₹124.1599945800274009725839719 | 66,421 | BSE |
11 Mar, 2022 | Manish Gupta | Disposal | ₹125.20 | 54,230 | BSE |
11 Mar, 2022 | Manish Gupta | Disposal | ₹124.0799430109229064429317714 | 6,317 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
01 Jul, 2021 | Rs.0.5000 per share(25%)Final Dividend | 08 Sept, 2021 | 10 Sept, 2021 |
Announcements
Date | Source | Detail |
---|---|---|
20 Feb, 2025 | BSE India | Postal Ballot-Scrutinizer''s Report |
17 Feb, 2025 | NSE India | Sequent Scientific Limited has informed the Exchange about Transcript |
17 Feb, 2025 | BSE India | Earning transcript Q3 FY25 |
13 Feb, 2025 | BSE India | Audio Recording of Earnings call pertaining to the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2024 |
13 Feb, 2025 | NSE India | Sequent Scientific Limited has informed the Exchange about Link of Recording |
12 Feb, 2025 | NSE India | Sequent Scientific Limited has informed the Exchange about Copy of Newspaper Publication |
11 Feb, 2025 | BSE India | Investor presentation Q3FY25 |
11 Feb, 2025 | NSE India | Sequent Scientific Limited has informed the Exchange about Investor Presentation |
11 Feb, 2025 | NSE India | Outcome of Board Meeting held on February 11, 2025, along with Unaudited Standalone andConsolidated Financial Results for the quarter and nine months ended December 31, 2024 |
11 Feb, 2025 | NSE India | Sequent Scientific Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 05 Feb, 2025 | 11 Feb, 2025 |
Quarterly Results | -- | 07 Nov, 2024 | 13 Nov, 2024 |
Quarterly Results | -- | 12 Aug, 2024 | 14 Aug, 2024 |
Audited Results & Final Dividend | -- | 10 May, 2024 | 15 May, 2024 |
Quarterly Results | -- | 07 Feb, 2024 | 13 Feb, 2024 |
Quarterly Results | -- | 31 Oct, 2023 | 06 Nov, 2023 |
Quarterly Results | -- | 07 Aug, 2023 | 10 Aug, 2023 |
Audited Results & Dividend | -- | 17 May, 2023 | 23 May, 2023 |
Quarterly Results | -- | 13 Feb, 2023 | 14 Feb, 2023 |
Quarterly Results & Preferential issue | -- | 02 Nov, 2022 | 07 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Sequent Scientific
Sequent Scientific is a Public Limited Listed company incorporated on 28/06/1985 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1985PLC036685 and registration number is 036685. Currently Company is involved in the business activities of Manufacture of veterinary preparations. Company’s Total Operating Revenue is Rs. 168.52 Cr. and Equity Capital is Rs. 49.89 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Strides Group
Founded
1985
Managing Director
Mr. Rajaram Narayanan
NSE Symbol
SEQUENT
Sequent Scientific Management
Name | Designation |
---|---|
Dr. Kamal K Sharma | Chairman & Ind.Director |
Mr. Rajaram Narayanan | Managing Director & CEO |
Mr. Sharat Narasapur | Joint Managing Director |
Mr. Gregory Andrews | Non Executive Director |
Mr. Neeraj Bharadwaj | Non Executive Director |
Dr. Fabian Kausche | Non Executive Director |
Dr. Hari Babu Bodepudi | Non Executive Director |
Mr. Milind Sarwate | Independent Director |
Dr.(Mrs.) Kausalya Santhanam | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
SunPhrmInds | ₹4,46,576.22 | ₹1,643.75 ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Sequent Scientific
What is the share price of Sequent Scientific?
The share price of Sequent Scientific on 21 Feb, 2025 is ₹ 158.75.
What is 52W high and 52W low share price of Sequent Scientific?
The highest and lowest 52W share prices of Sequent Scientific are ₹ 240.900 and ₹ 91.850
What is the market cap of Sequent Scientific?
The market capitalization of Sequent Scientific as of 21 Feb, 2025 is ₹ 3,982.04 Crores
What is the P/E ratio of Sequent Scientific?
The current P/E ratio of Sequent Scientific as of 21 Feb, 2025 is 44.81
What is the PB ratio of Sequent Scientific?
The PB ratio of Sequent Scientific as of 21 Feb, 2025 is 5.58
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)